Health Ministry Continues Sector-Wide Negotiations on Drug Policy Changes

Slovakia's Ministry of Health is conducting ongoing sector-wide negotiations regarding changes to the country's pharmaceutical policy. Wednesday's meeting focused primarily on so-called exceptional drugs, which typically refer to high-cost medications used for rare diseases or specialized treatments that require special approval and funding mechanisms. The discussions represent part of broader efforts to reform how medications are regulated, approved, and funded within Slovakia's healthcare system.